Lv5
1026 积分 2023-09-22 加入
Autoantibodies in Japanese patients with ocular myasthenia gravis
12天前
已完结
Clinical features of LRP4 /agrin‐antibody–positive myasthenia gravis: A multicenter study
13天前
已完结
The changing landscape of autoantibody testing in myasthenia gravis in the setting of novel drug treatments
13天前
已完结
Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders
13天前
已完结
Double seronegative myasthenia gravis and mimics: a retrospective cross-sectional study by two tertiary centers in the Southern Italy
19天前
已完结
Rituximab as induction therapy in refractory myasthenia gravis: 18 month follow-up study
1个月前
已完结
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
1个月前
已完结
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
1个月前
已完结
Subgroup stratification and outcome in recently diagnosed generalized myasthenia gravis
1个月前
已完结
Telitacicept in combination with B-cell depletion therapy in MuSK antibody-positive myasthenia gravis: a case report and literature review
1个月前
已完结
皖公网安备34019202002308
